BNTC vs PPL · $388.7M cap vs P/E 22, rev $8.46B
Benitec Biopharma Ltd ADR (BNTC) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Benitec Biopharma Ltd ADR (BNTC) is a biotechnology company listed on NASDAQ.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported BNTC revenue for 2025-09-30 was $0. Net income was -$9.0M. BNTC currently screens at market cap $388.7M.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
BNTC currently screens at market cap $388.7M. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the BNTC and PPL stock pages for the full models.
Not investment advice.